Why Is Everyone Talking About Teladoc Stock?
Leading telemedicine provider Teladoc Health (NYSE: TDOC) has seen demand for its services soar in 2020 as more and more patients are choosing to consult with doctors online rather than in person due to the COVID-19 pandemic. As a result, its share price has climbed 150% since the start of the year, and its market cap has nearly tripled to $18 billion.
The question now is whether Teladoc's strength will continue beyond the coronavirus crisis. With states and countries now allowing medical practices to operate, many people may go back to seeing their doctors in the traditional way. Others may chose to wait until a coronavirus vaccine becomes available to them before they resume in-person visits. Or maybe not. Let's take a closer look at Teladoc's amazing first half and its future prospects.
Image source: Getty Images.
Source Fool.com